INTRODUCTION/AIMS: While patients with type 1 diabetes (T1D) are known to suffer from early cardiovascular disease (CVD), we examined associations between arterial stiffness and diabetic complications in a large patient group with T1D. METHODS: This study included 807 subjects (622 T1D and 185 healthy volunteers (age 40.6 ± 0.7 versus 41.6 ± 1.2 years; P = NS)). Arterial stiffness was measured by pulse wave analysis from each participant. Furthermore, information on diabetic retinopathy, nephropathy, and CVD was collected. The renal status was verified from at least two out of three urine collections. RESULTS: Patients with T1D without signs of diabetic nephropathy had stiffer arteries measured as the augmentation index (AIx) than age-matched control subjects (17.3% ± 0.6% versus 10.0% ± 1.2%; P < 0.001). Moreover, AIx (OR 1.08; 95% CI 1.03-1.13; P = 0.002) was associated with diabetic laser-treated retinopathy in patients with normoalbuminuria in a multivariate logistic regression analysis. The same was true for AIx and diabetic nephropathy (1.04 (1.01-1.08); P = 0.004) as well as AIx and CVD (1.06 (1.00-1.12); P = 0.01) in patients with T1D. CONCLUSIONS: Arterial stiffness was associated with microvascular and macrovascular complications in patients with T1D.
INTRODUCTION/AIMS: While patients with type 1 diabetes (T1D) are known to suffer from early cardiovascular disease (CVD), we examined associations between arterial stiffness and diabetic complications in a large patient group with T1D. METHODS: This study included 807 subjects (622 T1D and 185 healthy volunteers (age 40.6 ± 0.7 versus 41.6 ± 1.2 years; P = NS)). Arterial stiffness was measured by pulse wave analysis from each participant. Furthermore, information on diabetic retinopathy, nephropathy, and CVD was collected. The renal status was verified from at least two out of three urine collections. RESULTS:Patients with T1D without signs of diabetic nephropathy had stiffer arteries measured as the augmentation index (AIx) than age-matched control subjects (17.3% ± 0.6% versus 10.0% ± 1.2%; P < 0.001). Moreover, AIx (OR 1.08; 95% CI 1.03-1.13; P = 0.002) was associated with diabetic laser-treated retinopathy in patients with normoalbuminuria in a multivariate logistic regression analysis. The same was true for AIx and diabetic nephropathy (1.04 (1.01-1.08); P = 0.004) as well as AIx and CVD (1.06 (1.00-1.12); P = 0.01) in patients with T1D. CONCLUSIONS: Arterial stiffness was associated with microvascular and macrovascular complications in patients with T1D.
Authors: S Theilade; B Claggett; T W Hansen; H Skali; E F Lewis; S D Solomon; H-H Parving; M Pfeffer; J J McMurray; P Rossing Journal: J Hum Hypertens Date: 2015-03-26 Impact factor: 3.012
Authors: Jussi Inkeri; Anniina Tynjälä; Carol Forsblom; Ron Liebkind; Turgut Tatlisumak; Lena M Thorn; Per-Henrik Groop; Sara Shams; Jukka Putaala; Juha Martola; Daniel Gordin Journal: Acta Diabetol Date: 2021-03-20 Impact factor: 4.280
Authors: Daniel Gordin; Johan Wadén; Carol Forsblom; Lena Thorn; Milla Rosengård-Bärlund; Nina Tolonen; Markku Saraheimo; Valma Harjutsalo; Per-Henrik Groop Journal: Diabetes Care Date: 2011-02-17 Impact factor: 19.112
Authors: Yvonne Searls; Irina V Smirnova; Lisa Vanhoose; Barbara Fegley; Rajprasad Loganathan; Lisa Stehno-Bittel Journal: Exp Diabetes Res Date: 2012-01-23
Authors: Roshini Prakash; Payaningal R Somanath; Azza B El-Remessy; Aisha Kelly-Cobbs; Javier E Stern; Paula Dore-Duffy; Maribeth Johnson; Susan C Fagan; Adviye Ergul Journal: Diabetes Date: 2012-03-08 Impact factor: 9.461
Authors: Simone Theilade; Maria Lajer; Frederik Persson; Christel Joergensen; Peter Rossing Journal: Diabetes Care Date: 2012-11-27 Impact factor: 19.112